MTOR and Ewing sarcoma: This notion is supported by the finding of the TC71 Ewing Sarcoma cell line showing resistance to the SMO inhibitor cyclopamine40, while being highly susceptible to combined PI3Kα and mTOR inhibition in the nanomolar range.